Headline »
Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) For The Treatment Of Fabry Disease
Wed, 24/06/09 – 7:42 | No Comment

Amicus Therapeutics (Nasdaq: FOLD) announced it has commenced the U.S. registration Phase 3 trial with its investigational drug, Amigal(TM) (migalastat hydrochloride) for the treatment of Fabry disease. The Company has reached agreement with the …

Read the full story »
Aim to Cure

A focus on disease-specific efforts by pharmaceutical and biotech companies

Analysis

Read in depth analysis by industry experts on investing opportunities and business strategies

Company Profiles

Learn about corporate strategies, positioning and investing opportunities

Industry News

Stay on top of the industry with our industry news bulletin

Mutual Funds

Diversify to hedge your investment during economic turbulence

Home » Archive by Category

Articles in Company Profiles

Pharmacy Online
Monday, 11 May, 2009 – 4:00 | No Comment
Pharmacy Online

www.Pharmacy-Online.com is Canada’s leading mail order pharmacy and has been in business since 2001 providing hundreds of thousands of Americans with safe affordable prescription medications.  www.Pharmacy-Online.com is a world leader in providing same, affordable prescription …

Allon Therapeutics
Monday, 30 Mar, 2009 – 20:01 | No Comment
Allon Therapeutics

Allon Therapeutics is a clinical stage biotechnology company focused on developing the first drugs that impact the progression of neurodegenerative diseases. Allon’s lead clinical program is focused on Alzheimer’s disease and as one of …

BioLytical Laboratories
Monday, 30 Mar, 2009 – 19:46 | No Comment
BioLytical Laboratories

Company Description:
BioLytical™ Laboratories is a private Richmond based company that develops and manufactures the world’s fastest rapid antibody point of care HIV diagnostic test called the INSTI™ Kit.
Technology Description:
The INSTI™ test begins by adding a …